| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholera | 113 | 2024 | 747 | 10.490 |
Why?
|
| Vibrio cholerae | 89 | 2023 | 793 | 7.230 |
Why?
|
| Vibrio cholerae O1 | 54 | 2024 | 243 | 5.810 |
Why?
|
| Antibodies, Bacterial | 78 | 2024 | 1469 | 3.990 |
Why?
|
| Cholera Vaccines | 39 | 2024 | 262 | 3.520 |
Why?
|
| O Antigens | 24 | 2024 | 196 | 2.320 |
Why?
|
| Bangladesh | 75 | 2023 | 736 | 2.290 |
Why?
|
| Antigens, Bacterial | 28 | 2019 | 1155 | 1.950 |
Why?
|
| Bacterial Proteins | 46 | 2015 | 3847 | 1.890 |
Why?
|
| Vibrio cholerae O139 | 13 | 2023 | 54 | 1.780 |
Why?
|
| Immunoglobulin A | 50 | 2024 | 978 | 1.700 |
Why?
|
| Cholera Toxin | 40 | 2024 | 559 | 1.660 |
Why?
|
| Immunologic Memory | 24 | 2022 | 1359 | 1.610 |
Why?
|
| Typhoid Fever | 14 | 2020 | 194 | 1.460 |
Why?
|
| Fimbriae Proteins | 15 | 2017 | 132 | 1.460 |
Why?
|
| Gene Expression Regulation, Bacterial | 26 | 2015 | 1133 | 1.450 |
Why?
|
| Genes, Bacterial | 28 | 2012 | 1073 | 1.250 |
Why?
|
| Escherichia coli O157 | 8 | 2015 | 53 | 1.210 |
Why?
|
| Salmonella typhi | 13 | 2020 | 198 | 1.210 |
Why?
|
| Escherichia coli Proteins | 14 | 2016 | 1067 | 1.030 |
Why?
|
| Diarrhea | 19 | 2024 | 1318 | 1.020 |
Why?
|
| Feces | 20 | 2024 | 1497 | 0.980 |
Why?
|
| Immunoglobulin M | 24 | 2024 | 1527 | 0.920 |
Why?
|
| Bacterial Toxins | 20 | 2016 | 931 | 0.910 |
Why?
|
| Immunoglobulin G | 56 | 2024 | 4544 | 0.900 |
Why?
|
| B-Lymphocytes | 23 | 2022 | 4758 | 0.850 |
Why?
|
| Virulence | 29 | 2015 | 1303 | 0.850 |
Why?
|
| Bacterial Outer Membrane Proteins | 16 | 2015 | 406 | 0.820 |
Why?
|
| Caenorhabditis elegans | 13 | 2009 | 1456 | 0.750 |
Why?
|
| Cryptococcus neoformans | 7 | 2009 | 121 | 0.720 |
Why?
|
| Bacteremia | 10 | 2015 | 979 | 0.710 |
Why?
|
| Immunity, Mucosal | 11 | 2020 | 483 | 0.710 |
Why?
|
| Iron | 20 | 2001 | 1793 | 0.710 |
Why?
|
| Escherichia coli Infections | 7 | 2017 | 518 | 0.670 |
Why?
|
| Bacterial Typing Techniques | 5 | 2014 | 263 | 0.670 |
Why?
|
| Antibody-Producing Cells | 8 | 2021 | 140 | 0.650 |
Why?
|
| Endocarditis, Bacterial | 5 | 2013 | 436 | 0.610 |
Why?
|
| Enterococcus faecalis | 8 | 2004 | 245 | 0.610 |
Why?
|
| Enterotoxins | 9 | 2016 | 367 | 0.590 |
Why?
|
| Lipopolysaccharides | 19 | 2023 | 2206 | 0.580 |
Why?
|
| Genome, Bacterial | 8 | 2024 | 783 | 0.540 |
Why?
|
| Blood Group Antigens | 3 | 2023 | 184 | 0.510 |
Why?
|
| Enterotoxigenic Escherichia coli | 5 | 2017 | 32 | 0.510 |
Why?
|
| Vaccines, Conjugate | 11 | 2023 | 328 | 0.500 |
Why?
|
| Bacteriophages | 7 | 2013 | 378 | 0.480 |
Why?
|
| Infectious Disease Medicine | 1 | 2015 | 49 | 0.480 |
Why?
|
| Mutagenesis, Insertional | 11 | 2004 | 656 | 0.470 |
Why?
|
| Vaccines, Synthetic | 9 | 2009 | 616 | 0.470 |
Why?
|
| Regulon | 3 | 1999 | 71 | 0.460 |
Why?
|
| Bacterial Vaccines | 9 | 2009 | 401 | 0.460 |
Why?
|
| History of Medicine | 1 | 2014 | 42 | 0.460 |
Why?
|
| Antibody Formation | 11 | 2024 | 1395 | 0.450 |
Why?
|
| Device Approval | 1 | 2015 | 163 | 0.450 |
Why?
|
| Streptococcus mutans | 1 | 2013 | 100 | 0.430 |
Why?
|
| Receptors, Cell Surface | 9 | 1998 | 2822 | 0.420 |
Why?
|
| Escherichia coli | 19 | 2016 | 4217 | 0.420 |
Why?
|
| Vaccination | 12 | 2024 | 3384 | 0.420 |
Why?
|
| Immunoglobulin A, Secretory | 2 | 2003 | 104 | 0.410 |
Why?
|
| Adhesins, Bacterial | 4 | 2012 | 118 | 0.410 |
Why?
|
| Repressor Proteins | 10 | 2001 | 2986 | 0.410 |
Why?
|
| Disease Outbreaks | 9 | 2018 | 1749 | 0.410 |
Why?
|
| Vaccines, Attenuated | 10 | 2017 | 315 | 0.400 |
Why?
|
| DNA, Bacterial | 19 | 2015 | 1479 | 0.400 |
Why?
|
| Molecular Sequence Data | 35 | 2015 | 17635 | 0.380 |
Why?
|
| Oxazoles | 4 | 2000 | 199 | 0.380 |
Why?
|
| Government Regulation | 1 | 2015 | 524 | 0.370 |
Why?
|
| Bone Marrow Transplantation | 10 | 2004 | 2693 | 0.370 |
Why?
|
| Streptococcal Infections | 3 | 2013 | 617 | 0.360 |
Why?
|
| Antibodies, Protozoan | 4 | 2012 | 252 | 0.360 |
Why?
|
| Child, Preschool | 63 | 2024 | 42230 | 0.360 |
Why?
|
| Operon | 4 | 2000 | 372 | 0.350 |
Why?
|
| T-Lymphocyte Subsets | 5 | 2018 | 1802 | 0.350 |
Why?
|
| Fimbriae, Bacterial | 3 | 2005 | 138 | 0.340 |
Why?
|
| Catechols | 4 | 2000 | 62 | 0.340 |
Why?
|
| Immunity, Innate | 9 | 2019 | 3065 | 0.340 |
Why?
|
| Administration, Oral | 20 | 2021 | 4021 | 0.340 |
Why?
|
| Disease Susceptibility | 4 | 2021 | 1787 | 0.340 |
Why?
|
| Cryptosporidiosis | 4 | 2012 | 52 | 0.340 |
Why?
|
| Base Sequence | 27 | 2013 | 12441 | 0.340 |
Why?
|
| Communicable Diseases | 2 | 2017 | 875 | 0.340 |
Why?
|
| Gene Expression Profiling | 12 | 2018 | 9420 | 0.330 |
Why?
|
| Disease Models, Animal | 16 | 2021 | 18252 | 0.330 |
Why?
|
| DNA-Binding Proteins | 10 | 2003 | 9606 | 0.330 |
Why?
|
| Adolescent | 74 | 2024 | 88319 | 0.320 |
Why?
|
| Serologic Tests | 3 | 2020 | 381 | 0.320 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2009 | 64 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2009 | 127 | 0.320 |
Why?
|
| Vaccines, Inactivated | 11 | 2023 | 179 | 0.310 |
Why?
|
| Shiga Toxins | 7 | 1999 | 40 | 0.310 |
Why?
|
| Humans | 197 | 2024 | 761504 | 0.310 |
Why?
|
| Drug Approval | 1 | 2015 | 814 | 0.310 |
Why?
|
| Paratyphoid Fever | 3 | 2013 | 34 | 0.310 |
Why?
|
| Helminthiasis | 1 | 2009 | 81 | 0.310 |
Why?
|
| Transcription Factors | 12 | 2003 | 12128 | 0.300 |
Why?
|
| Gastrointestinal Tract | 4 | 2024 | 833 | 0.300 |
Why?
|
| Drug Discovery | 1 | 2015 | 1051 | 0.290 |
Why?
|
| Transcription, Genetic | 14 | 2007 | 7594 | 0.290 |
Why?
|
| Antibody Specificity | 4 | 2019 | 1060 | 0.280 |
Why?
|
| Adult | 91 | 2024 | 221177 | 0.280 |
Why?
|
| Proteome | 5 | 2013 | 1862 | 0.280 |
Why?
|
| Mucous Membrane | 5 | 2019 | 659 | 0.280 |
Why?
|
| United States Food and Drug Administration | 1 | 2015 | 1664 | 0.280 |
Why?
|
| Genes, Regulator | 4 | 1998 | 373 | 0.280 |
Why?
|
| Child | 64 | 2024 | 80153 | 0.280 |
Why?
|
| Disease Transmission, Infectious | 3 | 2011 | 559 | 0.270 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3156 | 0.270 |
Why?
|
| Heart Valve Prosthesis | 6 | 2001 | 1462 | 0.270 |
Why?
|
| Genetic Complementation Test | 9 | 2002 | 554 | 0.270 |
Why?
|
| Methicillin-Resistant Staphylococcus aureus | 1 | 2013 | 698 | 0.270 |
Why?
|
| Systems Biology | 1 | 2010 | 481 | 0.270 |
Why?
|
| Immune Sera | 2 | 2015 | 606 | 0.270 |
Why?
|
| Cryptosporidium | 4 | 2012 | 41 | 0.270 |
Why?
|
| Neuraminidase | 3 | 2022 | 196 | 0.270 |
Why?
|
| Education, Medical, Graduate | 2 | 2017 | 2373 | 0.270 |
Why?
|
| Amino Acid Sequence | 23 | 2013 | 13446 | 0.270 |
Why?
|
| Family Characteristics | 8 | 2018 | 1004 | 0.260 |
Why?
|
| Duodenum | 5 | 2022 | 490 | 0.260 |
Why?
|
| Chromosomes, Bacterial | 5 | 2013 | 281 | 0.260 |
Why?
|
| Immunity, Humoral | 2 | 2020 | 606 | 0.260 |
Why?
|
| Intestines | 7 | 2015 | 1909 | 0.250 |
Why?
|
| Young Adult | 47 | 2021 | 59243 | 0.250 |
Why?
|
| Promoter Regions, Genetic | 14 | 2009 | 5789 | 0.250 |
Why?
|
| Recombinant Proteins | 10 | 2016 | 6534 | 0.250 |
Why?
|
| Neutropenia | 3 | 2001 | 885 | 0.240 |
Why?
|
| Travel | 2 | 2001 | 796 | 0.240 |
Why?
|
| Prosthesis-Related Infections | 2 | 2001 | 488 | 0.240 |
Why?
|
| Endophthalmitis | 3 | 2004 | 260 | 0.230 |
Why?
|
| Vaccines, Combined | 2 | 2021 | 70 | 0.230 |
Why?
|
| Salmonella paratyphi A | 3 | 2016 | 47 | 0.230 |
Why?
|
| Plasmids | 7 | 2017 | 2269 | 0.230 |
Why?
|
| Female | 110 | 2022 | 392644 | 0.230 |
Why?
|
| Antibody Affinity | 3 | 2014 | 246 | 0.230 |
Why?
|
| Staphylococcus aureus | 5 | 2006 | 1458 | 0.230 |
Why?
|
| Immunity, Cellular | 2 | 2009 | 1560 | 0.230 |
Why?
|
| Shigella Vaccines | 1 | 2023 | 10 | 0.220 |
Why?
|
| Carrier State | 2 | 2020 | 523 | 0.220 |
Why?
|
| RNA, Bacterial | 7 | 2011 | 393 | 0.220 |
Why?
|
| Convalescence | 3 | 2021 | 105 | 0.220 |
Why?
|
| Bacteriological Techniques | 2 | 2018 | 275 | 0.220 |
Why?
|
| Fungal Proteins | 2 | 2004 | 910 | 0.210 |
Why?
|
| Male | 93 | 2022 | 360804 | 0.210 |
Why?
|
| Mice | 42 | 2023 | 81525 | 0.210 |
Why?
|
| Biological Assay | 2 | 2004 | 626 | 0.210 |
Why?
|
| Shigella | 1 | 2023 | 68 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 8 | 2018 | 6075 | 0.210 |
Why?
|
| Animals | 69 | 2023 | 168459 | 0.210 |
Why?
|
| Dysentery, Bacillary | 1 | 2023 | 73 | 0.210 |
Why?
|
| T-Lymphocytes | 7 | 2015 | 10194 | 0.210 |
Why?
|
| Societies, Medical | 1 | 2015 | 3905 | 0.210 |
Why?
|
| Gene Deletion | 6 | 2013 | 2665 | 0.210 |
Why?
|
| Ferrichrome | 2 | 2000 | 3 | 0.210 |
Why?
|
| Polymorphism, Genetic | 3 | 2011 | 4243 | 0.210 |
Why?
|
| Staphylococcus epidermidis | 3 | 2007 | 123 | 0.200 |
Why?
|
| Genetic Vectors | 7 | 2000 | 3395 | 0.200 |
Why?
|
| Enzyme-Linked Immunospot Assay | 3 | 2017 | 123 | 0.200 |
Why?
|
| Antigens, Protozoan | 3 | 2012 | 316 | 0.200 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2002 | 166 | 0.200 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1996 | 891 | 0.200 |
Why?
|
| Bacterial Adhesion | 4 | 2015 | 306 | 0.190 |
Why?
|
| Cloning, Molecular | 11 | 2002 | 4174 | 0.190 |
Why?
|
| Pseudomonas aeruginosa | 4 | 2003 | 1277 | 0.190 |
Why?
|
| Infant | 34 | 2021 | 36192 | 0.190 |
Why?
|
| Listeriosis | 2 | 2002 | 149 | 0.190 |
Why?
|
| Entamoeba histolytica | 2 | 2000 | 29 | 0.190 |
Why?
|
| Genetic Variation | 6 | 2024 | 6567 | 0.190 |
Why?
|
| Salmonella enterica | 2 | 2016 | 76 | 0.190 |
Why?
|
| Anthozoa | 1 | 2021 | 66 | 0.190 |
Why?
|
| Colony Count, Microbial | 3 | 2012 | 330 | 0.180 |
Why?
|
| Parasitic Diseases | 1 | 2021 | 76 | 0.180 |
Why?
|
| Immunoglobulin Isotypes | 1 | 2021 | 158 | 0.180 |
Why?
|
| Phylogeny | 9 | 2024 | 2811 | 0.180 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2001 | 53 | 0.180 |
Why?
|
| Gram-Positive Bacterial Infections | 2 | 2004 | 343 | 0.180 |
Why?
|
| Typhoid-Paratyphoid Vaccines | 1 | 2020 | 39 | 0.180 |
Why?
|
| Fungi | 1 | 2003 | 338 | 0.180 |
Why?
|
| Restriction Mapping | 8 | 1997 | 851 | 0.180 |
Why?
|
| Peroxidase | 2 | 2021 | 609 | 0.180 |
Why?
|
| Contact Tracing | 2 | 2014 | 271 | 0.170 |
Why?
|
| Blood Bactericidal Activity | 6 | 2012 | 124 | 0.170 |
Why?
|
| Carrier Proteins | 4 | 1999 | 4936 | 0.170 |
Why?
|
| RNA, Messenger | 11 | 2016 | 12795 | 0.170 |
Why?
|
| Glutamate-Ammonia Ligase | 1 | 2000 | 75 | 0.170 |
Why?
|
| Peptide Synthases | 1 | 2000 | 80 | 0.170 |
Why?
|
| Interleukin-23 Subunit p19 | 1 | 2019 | 23 | 0.170 |
Why?
|
| Polysaccharides, Bacterial | 4 | 2020 | 578 | 0.170 |
Why?
|
| Species Specificity | 8 | 2015 | 2414 | 0.170 |
Why?
|
| Antibodies, Monoclonal | 4 | 2021 | 9177 | 0.170 |
Why?
|
| Metagenomics | 2 | 2021 | 467 | 0.170 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2017 | 1844 | 0.160 |
Why?
|
| Sequence Homology, Nucleic Acid | 8 | 2005 | 1058 | 0.160 |
Why?
|
| Staphylococcal Infections | 5 | 2007 | 1408 | 0.160 |
Why?
|
| Bacteria | 4 | 2006 | 2199 | 0.160 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 563 | 0.160 |
Why?
|
| Gene Transfer, Horizontal | 2 | 2017 | 145 | 0.150 |
Why?
|
| Membrane Proteins | 5 | 2009 | 7856 | 0.150 |
Why?
|
| Blood | 2 | 2011 | 596 | 0.150 |
Why?
|
| Middle Aged | 54 | 2022 | 220895 | 0.150 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 4 | 2004 | 142 | 0.150 |
Why?
|
| Gene Library | 4 | 2006 | 1059 | 0.150 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2001 | 629 | 0.150 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 6 | 2020 | 3810 | 0.150 |
Why?
|
| Immunoassay | 2 | 2020 | 745 | 0.150 |
Why?
|
| Protozoan Vaccines | 1 | 1997 | 13 | 0.150 |
Why?
|
| Meningoencephalitis | 1 | 1998 | 83 | 0.150 |
Why?
|
| Molecular Typing | 2 | 2015 | 116 | 0.150 |
Why?
|
| Haiti | 6 | 2017 | 550 | 0.150 |
Why?
|
| Transformation, Bacterial | 2 | 2015 | 76 | 0.150 |
Why?
|
| Leukemia, Myeloid | 2 | 2001 | 694 | 0.150 |
Why?
|
| Alkaline Phosphatase | 6 | 2000 | 864 | 0.150 |
Why?
|
| Adenosine Triphosphatases | 1 | 2002 | 835 | 0.150 |
Why?
|
| Cervix Uteri | 1 | 2001 | 570 | 0.150 |
Why?
|
| Models, Animal | 2 | 2003 | 2112 | 0.140 |
Why?
|
| Culture Media | 3 | 2010 | 897 | 0.140 |
Why?
|
| Shiga Toxin 1 | 9 | 1995 | 42 | 0.140 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2002 | 2748 | 0.140 |
Why?
|
| Rabbits | 7 | 2010 | 4772 | 0.140 |
Why?
|
| Hemolysin Proteins | 1 | 1997 | 113 | 0.140 |
Why?
|
| Adjuvants, Immunologic | 3 | 2012 | 1036 | 0.140 |
Why?
|
| Lymphocytes | 3 | 2022 | 2612 | 0.140 |
Why?
|
| Tropical Medicine | 1 | 2017 | 51 | 0.140 |
Why?
|
| Microbial Viability | 4 | 2011 | 238 | 0.140 |
Why?
|
| DNA Primers | 6 | 2009 | 2819 | 0.140 |
Why?
|
| Aldehyde Oxidoreductases | 1 | 1997 | 87 | 0.140 |
Why?
|
| Cryptococcosis | 3 | 2009 | 104 | 0.140 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2019 | 416 | 0.130 |
Why?
|
| DNA Helicases | 1 | 2002 | 851 | 0.130 |
Why?
|
| Recombinant Fusion Proteins | 7 | 2001 | 3734 | 0.130 |
Why?
|
| Bacillus anthracis | 2 | 2008 | 122 | 0.130 |
Why?
|
| Sequence Analysis, DNA | 9 | 2015 | 4740 | 0.130 |
Why?
|
| Moths | 2 | 2007 | 81 | 0.130 |
Why?
|
| Endocarditis | 3 | 2001 | 348 | 0.130 |
Why?
|
| Trisaccharides | 1 | 1996 | 50 | 0.130 |
Why?
|
| Urban Population | 1 | 2004 | 2036 | 0.130 |
Why?
|
| Anti-Bacterial Agents | 14 | 2015 | 7407 | 0.130 |
Why?
|
| HLA-DR Antigens | 1 | 2017 | 602 | 0.130 |
Why?
|
| Hybridization, Genetic | 1 | 2015 | 103 | 0.130 |
Why?
|
| Clinical Clerkship | 1 | 2022 | 564 | 0.130 |
Why?
|
| DNA Probes | 1 | 2016 | 541 | 0.130 |
Why?
|
| Tetanus Toxin | 1 | 2015 | 46 | 0.130 |
Why?
|
| Interferon-gamma | 3 | 2014 | 3162 | 0.130 |
Why?
|
| Mutagenesis | 5 | 2002 | 1232 | 0.130 |
Why?
|
| Integrin beta Chains | 1 | 2015 | 115 | 0.130 |
Why?
|
| Interspersed Repetitive Sequences | 1 | 2015 | 53 | 0.130 |
Why?
|
| Virulence Factors | 4 | 2011 | 513 | 0.120 |
Why?
|
| Blotting, Southern | 6 | 2001 | 777 | 0.120 |
Why?
|
| Intestinal Mucosa | 4 | 2022 | 3032 | 0.120 |
Why?
|
| Bacterial Shedding | 1 | 2014 | 10 | 0.120 |
Why?
|
| Intestine, Small | 4 | 2012 | 1206 | 0.120 |
Why?
|
| Plasma | 1 | 2018 | 586 | 0.120 |
Why?
|
| Magnetite Nanoparticles | 1 | 2016 | 318 | 0.120 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2004 | 1551 | 0.120 |
Why?
|
| Administration, Cutaneous | 6 | 2020 | 713 | 0.120 |
Why?
|
| Siderophores | 1 | 1994 | 61 | 0.120 |
Why?
|
| Cytotoxins | 2 | 2001 | 153 | 0.120 |
Why?
|
| Receptors, Virus | 2 | 2012 | 640 | 0.110 |
Why?
|
| Sequence Deletion | 5 | 2006 | 1494 | 0.110 |
Why?
|
| Cohort Studies | 14 | 2022 | 41487 | 0.110 |
Why?
|
| Gastrointestinal Diseases | 3 | 2021 | 1200 | 0.110 |
Why?
|
| Biofilms | 2 | 2010 | 628 | 0.110 |
Why?
|
| Microbial Sensitivity Tests | 6 | 2010 | 1937 | 0.110 |
Why?
|
| Fresh Water | 3 | 2009 | 82 | 0.110 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17904 | 0.110 |
Why?
|
| Gelatinases | 2 | 2004 | 88 | 0.110 |
Why?
|
| Protozoan Proteins | 2 | 2011 | 847 | 0.110 |
Why?
|
| DNA Transposable Elements | 7 | 2009 | 755 | 0.110 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2018 | 974 | 0.110 |
Why?
|
| Salmonella typhimurium | 2 | 2009 | 347 | 0.110 |
Why?
|
| Vibrio | 1 | 1993 | 40 | 0.110 |
Why?
|
| Genes, Fungal | 2 | 2005 | 439 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 506 | 0.100 |
Why?
|
| Family Health | 3 | 2018 | 1257 | 0.100 |
Why?
|
| Streptococcus | 3 | 1989 | 198 | 0.100 |
Why?
|
| Biliary Tract | 1 | 2013 | 135 | 0.100 |
Why?
|
| Immunization | 5 | 2015 | 1228 | 0.100 |
Why?
|
| Operator Regions, Genetic | 2 | 1990 | 33 | 0.100 |
Why?
|
| Bacteriolysis | 2 | 2013 | 50 | 0.100 |
Why?
|
| Intestinal Diseases | 1 | 2016 | 504 | 0.100 |
Why?
|
| Multigene Family | 3 | 2005 | 1076 | 0.100 |
Why?
|
| Chromosome Mapping | 6 | 2010 | 4615 | 0.100 |
Why?
|
| Genes, Viral | 1 | 2013 | 649 | 0.100 |
Why?
|
| Animals, Suckling | 3 | 2020 | 69 | 0.100 |
Why?
|
| Epithelial Cells | 2 | 2015 | 3673 | 0.100 |
Why?
|
| Dehydration | 2 | 2010 | 216 | 0.100 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2016 | 611 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1213 | 0.090 |
Why?
|
| Host-Pathogen Interactions | 3 | 2015 | 1459 | 0.090 |
Why?
|
| Immunodominant Epitopes | 1 | 2012 | 239 | 0.090 |
Why?
|
| Mice, Inbred Strains | 3 | 2005 | 1762 | 0.090 |
Why?
|
| Vancomycin | 4 | 2001 | 503 | 0.090 |
Why?
|
| Cytokines | 6 | 2019 | 7396 | 0.090 |
Why?
|
| Th1 Cells | 3 | 2012 | 1036 | 0.090 |
Why?
|
| Antitoxins | 3 | 2019 | 77 | 0.090 |
Why?
|
| Th2 Cells | 3 | 2012 | 1060 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 1999 | 1230 | 0.090 |
Why?
|
| Virus Shedding | 1 | 2011 | 111 | 0.090 |
Why?
|
| Membrane Transport Proteins | 1 | 1996 | 1035 | 0.090 |
Why?
|
| Mutation | 22 | 2015 | 30052 | 0.090 |
Why?
|
| Gene Expression Regulation | 7 | 2019 | 11903 | 0.090 |
Why?
|
| Evolution, Molecular | 4 | 2017 | 1886 | 0.090 |
Why?
|
| Monocytes | 1 | 2019 | 2570 | 0.090 |
Why?
|
| Germ-Free Life | 3 | 2000 | 189 | 0.080 |
Why?
|
| Oligosaccharides | 1 | 2012 | 406 | 0.080 |
Why?
|
| Agglutination | 2 | 2020 | 41 | 0.080 |
Why?
|
| Minisatellite Repeats | 1 | 2010 | 163 | 0.080 |
Why?
|
| Spirochaetales Infections | 1 | 2009 | 11 | 0.080 |
Why?
|
| Immunization, Secondary | 3 | 2021 | 367 | 0.080 |
Why?
|
| DNA Footprinting | 2 | 2000 | 97 | 0.080 |
Why?
|
| Immunization Schedule | 2 | 2020 | 227 | 0.080 |
Why?
|
| Animals, Newborn | 4 | 2011 | 2678 | 0.080 |
Why?
|
| Glucuronidase | 2 | 2001 | 202 | 0.080 |
Why?
|
| Receptors, Scavenger | 1 | 2009 | 123 | 0.080 |
Why?
|
| Severity of Illness Index | 4 | 2022 | 15842 | 0.080 |
Why?
|
| Antibiosis | 1 | 2008 | 45 | 0.080 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2012 | 15936 | 0.080 |
Why?
|
| Signal Transduction | 6 | 2018 | 23445 | 0.080 |
Why?
|
| Spectrophotometry, Atomic | 1 | 2008 | 82 | 0.080 |
Why?
|
| Quorum Sensing | 1 | 2010 | 137 | 0.080 |
Why?
|
| Fellowships and Scholarships | 1 | 2017 | 1117 | 0.080 |
Why?
|
| Floods | 1 | 2008 | 41 | 0.080 |
Why?
|
| Serotyping | 4 | 2015 | 325 | 0.080 |
Why?
|
| Fluid Therapy | 1 | 2012 | 579 | 0.080 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2011 | 3778 | 0.080 |
Why?
|
| Curriculum | 1 | 2022 | 3743 | 0.080 |
Why?
|
| Vitamin A | 2 | 2008 | 613 | 0.080 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2015 | 2151 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2014 | 1567 | 0.080 |
Why?
|
| Respiration, Artificial | 1 | 1999 | 2628 | 0.070 |
Why?
|
| Rotavirus | 1 | 2008 | 109 | 0.070 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2013 | 787 | 0.070 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2009 | 148 | 0.070 |
Why?
|
| Zinc | 2 | 2008 | 690 | 0.070 |
Why?
|
| Leptin | 1 | 2015 | 1597 | 0.070 |
Why?
|
| Exosomes | 1 | 2011 | 424 | 0.070 |
Why?
|
| Tularemia | 1 | 2007 | 42 | 0.070 |
Why?
|
| Age Distribution | 2 | 2014 | 2880 | 0.070 |
Why?
|
| Cross Reactions | 2 | 2020 | 817 | 0.070 |
Why?
|
| Time Factors | 11 | 2014 | 39967 | 0.070 |
Why?
|
| Acute Disease | 6 | 2018 | 7237 | 0.070 |
Why?
|
| Cluster Analysis | 2 | 2011 | 2707 | 0.070 |
Why?
|
| Francisella tularensis | 1 | 2007 | 62 | 0.070 |
Why?
|
| Azlocillin | 2 | 1984 | 19 | 0.070 |
Why?
|
| Vitamin K 3 | 1 | 2006 | 14 | 0.070 |
Why?
|
| Enterococcus faecium | 2 | 2004 | 101 | 0.070 |
Why?
|
| Quinolones | 1 | 2009 | 378 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2014 | 2767 | 0.070 |
Why?
|
| Serum Bactericidal Test | 1 | 2005 | 3 | 0.070 |
Why?
|
| Hemin | 1 | 2006 | 51 | 0.070 |
Why?
|
| Proteomics | 4 | 2016 | 3849 | 0.070 |
Why?
|
| Heat-Shock Proteins | 1 | 1990 | 795 | 0.070 |
Why?
|
| Infant, Newborn | 8 | 2024 | 26198 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 4 | 2009 | 874 | 0.060 |
Why?
|
| Cells, Cultured | 7 | 2015 | 18965 | 0.060 |
Why?
|
| Candida albicans | 1 | 2009 | 372 | 0.060 |
Why?
|
| Anthrax Vaccines | 1 | 2005 | 17 | 0.060 |
Why?
|
| Th17 Cells | 3 | 2022 | 794 | 0.060 |
Why?
|
| Conserved Sequence | 1 | 2009 | 1163 | 0.060 |
Why?
|
| Sequence Alignment | 4 | 2012 | 2180 | 0.060 |
Why?
|
| Chemotaxis | 2 | 2006 | 598 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2020 | 14666 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2001 | 2496 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2016 | 2449 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2013 | 5869 | 0.060 |
Why?
|
| Lac Operon | 2 | 2015 | 237 | 0.060 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2009 | 587 | 0.060 |
Why?
|
| Genomic Library | 1 | 2005 | 189 | 0.060 |
Why?
|
| Mice, Inbred ICR | 2 | 2002 | 364 | 0.060 |
Why?
|
| Melanins | 2 | 2007 | 290 | 0.060 |
Why?
|
| Immunologic Techniques | 1 | 2005 | 212 | 0.060 |
Why?
|
| Communicable Disease Control | 1 | 2011 | 846 | 0.060 |
Why?
|
| Bacterial Capsules | 1 | 2005 | 244 | 0.060 |
Why?
|
| Pedigree | 2 | 2009 | 4542 | 0.060 |
Why?
|
| Mucins | 1 | 2007 | 568 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2008 | 1541 | 0.060 |
Why?
|
| Bone Marrow | 1 | 1994 | 2911 | 0.060 |
Why?
|
| Risk Factors | 12 | 2022 | 74206 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2021 | 9646 | 0.060 |
Why?
|
| Linkage Disequilibrium | 1 | 2009 | 1998 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 2 | 2004 | 484 | 0.060 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 175 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 5486 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2020 | 20098 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2003 | 113 | 0.050 |
Why?
|
| Laccase | 1 | 2002 | 8 | 0.050 |
Why?
|
| Genes, Mating Type, Fungal | 1 | 2002 | 25 | 0.050 |
Why?
|
| Cryptococcus | 1 | 2002 | 28 | 0.050 |
Why?
|
| Sex Distribution | 1 | 2008 | 2281 | 0.050 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3084 | 0.050 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3204 | 0.050 |
Why?
|
| Haplotypes | 1 | 2009 | 2713 | 0.050 |
Why?
|
| Bacterial Load | 2 | 2014 | 152 | 0.050 |
Why?
|
| Heterotrimeric GTP-Binding Proteins | 1 | 2002 | 94 | 0.050 |
Why?
|
| Lysogeny | 1 | 2002 | 67 | 0.050 |
Why?
|
| Shigella flexneri | 1 | 2023 | 119 | 0.050 |
Why?
|
| Microscopy | 1 | 2007 | 903 | 0.050 |
Why?
|
| Anti-Infective Agents | 2 | 2001 | 983 | 0.050 |
Why?
|
| Survival Analysis | 7 | 2012 | 10090 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4369 | 0.050 |
Why?
|
| Mannose-Binding Lectin | 1 | 2003 | 145 | 0.050 |
Why?
|
| Chromatography, Affinity | 2 | 2010 | 532 | 0.050 |
Why?
|
| Case-Control Studies | 6 | 2017 | 22176 | 0.050 |
Why?
|
| Survival Rate | 5 | 2004 | 12725 | 0.050 |
Why?
|
| Bartonella | 1 | 2001 | 11 | 0.050 |
Why?
|
| ROC Curve | 2 | 2021 | 3579 | 0.050 |
Why?
|
| Levodopa | 1 | 2002 | 221 | 0.050 |
Why?
|
| Eye | 2 | 2004 | 712 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2005 | 569 | 0.050 |
Why?
|
| Bone Marrow Purging | 1 | 2001 | 108 | 0.050 |
Why?
|
| Gene Frequency | 1 | 2009 | 3606 | 0.050 |
Why?
|
| Free Radical Scavengers | 1 | 2002 | 211 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 652 | 0.050 |
Why?
|
| Incidence | 5 | 2019 | 21353 | 0.050 |
Why?
|
| Lymphocyte Count | 2 | 2001 | 778 | 0.050 |
Why?
|
| Genotype | 3 | 2015 | 12990 | 0.050 |
Why?
|
| Cattle | 3 | 2015 | 3849 | 0.050 |
Why?
|
| Amikacin | 1 | 1981 | 47 | 0.050 |
Why?
|
| Kanamycin | 1 | 1981 | 63 | 0.050 |
Why?
|
| Aged | 15 | 2024 | 169289 | 0.050 |
Why?
|
| Roseolovirus Infections | 1 | 2001 | 49 | 0.050 |
Why?
|
| Drug Design | 1 | 2006 | 1048 | 0.050 |
Why?
|
| Herpesvirus 6, Human | 1 | 2001 | 96 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2021 | 337 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 730 | 0.050 |
Why?
|
| Life Tables | 2 | 2001 | 364 | 0.040 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2001 | 102 | 0.040 |
Why?
|
| Hospitals | 2 | 2017 | 3882 | 0.040 |
Why?
|
| Artificial Gene Fusion | 1 | 2000 | 56 | 0.040 |
Why?
|
| Multivariate Analysis | 3 | 2014 | 12059 | 0.040 |
Why?
|
| Oxidoreductases | 1 | 2002 | 413 | 0.040 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2006 | 283 | 0.040 |
Why?
|
| Bacterial Infections | 2 | 2000 | 1390 | 0.040 |
Why?
|
| United States | 4 | 2018 | 72334 | 0.040 |
Why?
|
| Splenomegaly | 1 | 2001 | 189 | 0.040 |
Why?
|
| Mycoses | 2 | 2001 | 386 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2003 | 427 | 0.040 |
Why?
|
| Risk | 3 | 2007 | 9610 | 0.040 |
Why?
|
| Vaccines, Subunit | 1 | 2000 | 161 | 0.040 |
Why?
|
| Rivers | 2 | 2013 | 64 | 0.040 |
Why?
|
| Disasters | 1 | 2006 | 519 | 0.040 |
Why?
|
| Neutrophils | 3 | 2022 | 3767 | 0.040 |
Why?
|
| Macrophages | 3 | 2009 | 5769 | 0.040 |
Why?
|
| Alleles | 2 | 2009 | 6863 | 0.040 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2022 | 422 | 0.040 |
Why?
|
| Metronidazole | 1 | 2001 | 232 | 0.040 |
Why?
|
| Drug Evaluation | 1 | 2001 | 641 | 0.040 |
Why?
|
| Serum | 2 | 2011 | 209 | 0.040 |
Why?
|
| Receptor, Insulin | 1 | 2003 | 835 | 0.040 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2021 | 330 | 0.040 |
Why?
|
| Antigens | 1 | 2005 | 1443 | 0.040 |
Why?
|
| Meningitis, Listeria | 1 | 1998 | 4 | 0.040 |
Why?
|
| Vision, Ocular | 1 | 2002 | 455 | 0.040 |
Why?
|
| Serine Endopeptidases | 1 | 2004 | 1022 | 0.040 |
Why?
|
| Inflammasomes | 2 | 2015 | 526 | 0.040 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2001 | 264 | 0.040 |
Why?
|
| Leukemia, Myelomonocytic, Chronic | 1 | 1999 | 92 | 0.040 |
Why?
|
| Exotoxins | 1 | 1999 | 121 | 0.040 |
Why?
|
| Phagocytosis | 1 | 2004 | 1528 | 0.040 |
Why?
|
| Endotoxins | 1 | 2021 | 520 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1545 | 0.040 |
Why?
|
| Anemia, Aplastic | 1 | 2000 | 230 | 0.040 |
Why?
|
| HeLa Cells | 3 | 1999 | 3093 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2005 | 1841 | 0.040 |
Why?
|
| Genes, Overlapping | 1 | 1998 | 36 | 0.040 |
Why?
|
| Oxacillin | 1 | 1998 | 41 | 0.040 |
Why?
|
| Longevity | 2 | 2003 | 1065 | 0.040 |
Why?
|
| Consensus Sequence | 2 | 1999 | 365 | 0.040 |
Why?
|
| beta-Lactamases | 2 | 2015 | 304 | 0.040 |
Why?
|
| Binding Sites | 3 | 2000 | 6055 | 0.040 |
Why?
|
| Coagulase | 1 | 1998 | 54 | 0.040 |
Why?
|
| Recurrence | 5 | 2004 | 8465 | 0.040 |
Why?
|
| Ofloxacin | 1 | 1998 | 66 | 0.040 |
Why?
|
| RNA Stability | 1 | 2000 | 329 | 0.040 |
Why?
|
| Phosphotransferases (Nitrogenous Group Acceptor) | 1 | 2017 | 5 | 0.040 |
Why?
|
| Digestive System | 3 | 2004 | 244 | 0.040 |
Why?
|
| Brain Abscess | 1 | 1998 | 120 | 0.040 |
Why?
|
| Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 2017 | 23 | 0.040 |
Why?
|
| Probability | 2 | 2002 | 2477 | 0.040 |
Why?
|
| Staphylococcus | 1 | 1998 | 154 | 0.040 |
Why?
|
| Severe Combined Immunodeficiency | 1 | 2000 | 227 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4575 | 0.040 |
Why?
|
| Pneumonia, Bacterial | 1 | 2000 | 316 | 0.040 |
Why?
|
| Metagenome | 1 | 2021 | 450 | 0.040 |
Why?
|
| Phosphoglycerate Kinase | 1 | 1997 | 66 | 0.040 |
Why?
|
| Central Nervous System Diseases | 1 | 2001 | 520 | 0.040 |
Why?
|
| Prospective Studies | 7 | 2018 | 54425 | 0.040 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 1 | 1997 | 78 | 0.030 |
Why?
|
| CD40 Ligand | 1 | 2018 | 522 | 0.030 |
Why?
|
| Biological Evolution | 2 | 2013 | 1071 | 0.030 |
Why?
|
| Crosses, Genetic | 1 | 1998 | 749 | 0.030 |
Why?
|
| Glutamine | 1 | 2000 | 577 | 0.030 |
Why?
|
| Flagellin | 1 | 2017 | 124 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 1999 | 387 | 0.030 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2018 | 239 | 0.030 |
Why?
|
| Asia | 1 | 2018 | 619 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2011 | 6216 | 0.030 |
Why?
|
| Heart Valve Diseases | 3 | 1991 | 1027 | 0.030 |
Why?
|
| Ribosomes | 1 | 2000 | 501 | 0.030 |
Why?
|
| Proteins | 1 | 2011 | 6032 | 0.030 |
Why?
|
| Gene Expression | 3 | 2000 | 7581 | 0.030 |
Why?
|
| P Blood-Group System | 1 | 1996 | 3 | 0.030 |
Why?
|
| Down-Regulation | 2 | 2006 | 2919 | 0.030 |
Why?
|
| Hemocytes | 2 | 2007 | 44 | 0.030 |
Why?
|
| Vero Cells | 1 | 1997 | 482 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
| Africa | 1 | 2018 | 709 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1276 | 0.030 |
Why?
|
| Polysaccharides | 1 | 2002 | 1014 | 0.030 |
Why?
|
| Biological Transport, Active | 1 | 1996 | 328 | 0.030 |
Why?
|
| Shellfish | 1 | 1995 | 37 | 0.030 |
Why?
|
| Carbohydrate Conformation | 1 | 1996 | 206 | 0.030 |
Why?
|
| Myeloid Cells | 1 | 2001 | 823 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2016 | 3769 | 0.030 |
Why?
|
| Longitudinal Studies | 2 | 2022 | 14605 | 0.030 |
Why?
|
| Sepharose | 1 | 1996 | 103 | 0.030 |
Why?
|
| Chitin | 1 | 2015 | 33 | 0.030 |
Why?
|
| Cyclophosphamide | 1 | 2001 | 2218 | 0.030 |
Why?
|
| Transplantation, Autologous | 2 | 2001 | 2115 | 0.030 |
Why?
|
| Periplasm | 1 | 2015 | 40 | 0.030 |
Why?
|
| Gene Order | 1 | 2015 | 169 | 0.030 |
Why?
|
| Fever | 2 | 2000 | 1618 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1996 | 411 | 0.030 |
Why?
|
| Frameshift Mutation | 1 | 1997 | 392 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2448 | 0.030 |
Why?
|
| Glycosides | 1 | 1996 | 100 | 0.030 |
Why?
|
| Rumen | 1 | 2015 | 18 | 0.030 |
Why?
|
| Models, Biological | 3 | 2019 | 9469 | 0.030 |
Why?
|
| Conjugation, Genetic | 1 | 2015 | 116 | 0.030 |
Why?
|
| Tryptophan-tRNA Ligase | 1 | 2015 | 16 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2022 | 879 | 0.030 |
Why?
|
| Introns | 1 | 1998 | 981 | 0.030 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2015 | 57 | 0.030 |
Why?
|
| Skin Diseases, Bacterial | 1 | 1995 | 68 | 0.030 |
Why?
|
| Oligonucleotide Probes | 1 | 1995 | 416 | 0.030 |
Why?
|
| Computer Simulation | 2 | 2019 | 6240 | 0.030 |
Why?
|
| Indicators and Reagents | 1 | 1996 | 462 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2021 | 718 | 0.030 |
Why?
|
| DNA Mutational Analysis | 4 | 1992 | 4111 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 2004 | 1712 | 0.030 |
Why?
|
| Sepsis | 1 | 1989 | 2585 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2019 | 1638 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 2015 | 224 | 0.030 |
Why?
|
| Gels | 1 | 1996 | 420 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2008 | 3205 | 0.030 |
Why?
|
| Calgranulin A | 1 | 2015 | 80 | 0.030 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2014 | 84 | 0.030 |
Why?
|
| Age Factors | 3 | 2021 | 18395 | 0.030 |
Why?
|
| DNA, Viral | 1 | 2001 | 2202 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1997 | 2186 | 0.030 |
Why?
|
| Biopsy | 2 | 2018 | 6766 | 0.030 |
Why?
|
| Immunoglobulins | 1 | 2017 | 853 | 0.030 |
Why?
|
| Bile | 1 | 1995 | 298 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 1996 | 1624 | 0.030 |
Why?
|
| Hospitalization | 3 | 2021 | 10723 | 0.030 |
Why?
|
| Arabidopsis | 1 | 1997 | 465 | 0.030 |
Why?
|
| Deoxyribonucleases | 1 | 2015 | 211 | 0.030 |
Why?
|
| Prognosis | 5 | 2021 | 29625 | 0.030 |
Why?
|
| Heme | 1 | 1996 | 313 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1993 | 1434 | 0.030 |
Why?
|
| Double-Blind Method | 3 | 2018 | 12341 | 0.030 |
Why?
|
| Peer Review, Research | 1 | 2017 | 340 | 0.030 |
Why?
|
| Graft vs Host Disease | 4 | 2002 | 3029 | 0.030 |
Why?
|
| Lethal Dose 50 | 1 | 1993 | 72 | 0.030 |
Why?
|
| Phenotype | 3 | 2003 | 16591 | 0.030 |
Why?
|
| DNA, Complementary | 2 | 2010 | 1991 | 0.030 |
Why?
|
| Cholangitis, Sclerosing | 1 | 1995 | 177 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 382 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2017 | 793 | 0.030 |
Why?
|
| Epidemiologic Methods | 1 | 2018 | 1336 | 0.030 |
Why?
|
| Microspheres | 1 | 2016 | 784 | 0.030 |
Why?
|
| Prophages | 1 | 2013 | 39 | 0.030 |
Why?
|
| Logistic Models | 1 | 2008 | 13255 | 0.030 |
Why?
|
| Automation | 1 | 1996 | 586 | 0.030 |
Why?
|
| Bone Marrow Cells | 1 | 2001 | 2416 | 0.030 |
Why?
|
| Rectum | 2 | 2009 | 892 | 0.030 |
Why?
|
| Mannose-6-Phosphate Isomerase | 1 | 2012 | 5 | 0.030 |
Why?
|
| Genomic Islands | 1 | 2013 | 52 | 0.030 |
Why?
|
| Polymyxin B | 1 | 2012 | 44 | 0.030 |
Why?
|
| Inverted Repeat Sequences | 1 | 2013 | 60 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1994 | 767 | 0.030 |
Why?
|
| Hemagglutination | 1 | 1992 | 32 | 0.030 |
Why?
|
| Antibodies | 1 | 2021 | 2418 | 0.030 |
Why?
|
| Colon | 1 | 2001 | 1792 | 0.030 |
Why?
|
| Research Support as Topic | 1 | 2017 | 697 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2019 | 1440 | 0.030 |
Why?
|
| Temperature | 1 | 1999 | 2226 | 0.030 |
Why?
|
| Dominican Republic | 1 | 2012 | 76 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1615 | 0.030 |
Why?
|
| Viral Load | 1 | 2022 | 3332 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2015 | 588 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2001 | 8529 | 0.030 |
Why?
|
| Point Mutation | 1 | 2017 | 1595 | 0.030 |
Why?
|
| Placebos | 1 | 2017 | 1667 | 0.030 |
Why?
|
| Electrophoresis | 1 | 2012 | 227 | 0.030 |
Why?
|
| Nepal | 1 | 2013 | 305 | 0.030 |
Why?
|
| Learning | 1 | 2022 | 1740 | 0.030 |
Why?
|
| Norepinephrine | 1 | 2015 | 897 | 0.030 |
Why?
|
| Sequence Homology | 1 | 1992 | 196 | 0.030 |
Why?
|
| Protein Synthesis Inhibitors | 2 | 1992 | 189 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2013 | 400 | 0.020 |
Why?
|
| Cryptosporidium parvum | 1 | 2012 | 35 | 0.020 |
Why?
|
| Intensive Care Units, Pediatric | 1 | 1999 | 1017 | 0.020 |
Why?
|
| Genomics | 2 | 2018 | 5821 | 0.020 |
Why?
|
| Family | 2 | 2015 | 3194 | 0.020 |
Why?
|
| Cell Line | 4 | 2012 | 15601 | 0.020 |
Why?
|
| Bacteriophage Typing | 1 | 2011 | 3 | 0.020 |
Why?
|
| Eye Infections, Fungal | 1 | 1992 | 100 | 0.020 |
Why?
|
| Retina | 1 | 2002 | 2659 | 0.020 |
Why?
|
| Disease-Free Survival | 4 | 2004 | 6814 | 0.020 |
Why?
|
| Intubation, Intratracheal | 1 | 1999 | 1329 | 0.020 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 579 | 0.020 |
Why?
|
| Kinetics | 1 | 2019 | 6374 | 0.020 |
Why?
|
| Paneth Cells | 1 | 2011 | 98 | 0.020 |
Why?
|
| Biological Transport | 2 | 1993 | 2091 | 0.020 |
Why?
|
| Interleukin-10 | 1 | 2016 | 1175 | 0.020 |
Why?
|
| Mass Spectrometry | 2 | 2010 | 2192 | 0.020 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2009 | 238 | 0.020 |
Why?
|
| Ricin | 2 | 1988 | 70 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2000 | 4174 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 1943 | 0.020 |
Why?
|
| Meningitis, Bacterial | 1 | 1993 | 221 | 0.020 |
Why?
|
| Citrates | 1 | 1990 | 134 | 0.020 |
Why?
|
| Shiga Toxin 2 | 1 | 1990 | 21 | 0.020 |
Why?
|
| DNA, Protozoan | 1 | 2011 | 228 | 0.020 |
Why?
|
| Pandemics | 2 | 2020 | 8654 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2012 | 681 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2002 | 3188 | 0.020 |
Why?
|
| History, 18th Century | 1 | 2010 | 207 | 0.020 |
Why?
|
| Hemolysis | 1 | 1992 | 415 | 0.020 |
Why?
|
| Candidiasis | 2 | 2009 | 365 | 0.020 |
Why?
|
| Chickens | 1 | 1992 | 859 | 0.020 |
Why?
|
| Carbon | 1 | 1994 | 666 | 0.020 |
Why?
|
| DNA Topoisomerase IV | 1 | 2009 | 42 | 0.020 |
Why?
|
| Publishing | 1 | 2017 | 833 | 0.020 |
Why?
|
| Gentamicins | 1 | 1991 | 243 | 0.020 |
Why?
|
| Retrospective Studies | 8 | 2004 | 80636 | 0.020 |
Why?
|
| Erythromycin | 1 | 2010 | 115 | 0.020 |
Why?
|
| Chromatography, Gel | 1 | 1990 | 645 | 0.020 |
Why?
|
| Radiography | 1 | 2001 | 6965 | 0.020 |
Why?
|
| Ampicillin | 2 | 1987 | 136 | 0.020 |
Why?
|
| Brachyspira | 1 | 2009 | 3 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26125 | 0.020 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2011 | 296 | 0.020 |
Why?
|
| Opportunistic Infections | 1 | 1992 | 376 | 0.020 |
Why?
|
| Zimbabwe | 1 | 2009 | 135 | 0.020 |
Why?
|
| Transplantation Conditioning | 1 | 1996 | 1590 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2012 | 39106 | 0.020 |
Why?
|
| Tetracycline | 1 | 2010 | 216 | 0.020 |
Why?
|
| DNA Gyrase | 1 | 2009 | 85 | 0.020 |
Why?
|
| Genome, Viral | 1 | 2013 | 667 | 0.020 |
Why?
|
| DNA | 2 | 2015 | 7212 | 0.020 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 2009 | 94 | 0.020 |
Why?
|
| Echocardiography | 1 | 2001 | 4989 | 0.020 |
Why?
|
| Solubility | 1 | 1990 | 1091 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2011 | 469 | 0.020 |
Why?
|
| Milk | 1 | 2011 | 443 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2013 | 1791 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1994 | 3076 | 0.020 |
Why?
|
| Bacterial Translocation | 1 | 2008 | 73 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2013 | 868 | 0.020 |
Why?
|
| Serum Albumin, Bovine | 1 | 2009 | 321 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 4352 | 0.020 |
Why?
|
| Epidemics | 1 | 2014 | 512 | 0.020 |
Why?
|
| Endocarditis, Subacute Bacterial | 1 | 1987 | 8 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 1741 | 0.020 |
Why?
|
| Penicillins | 3 | 1991 | 402 | 0.020 |
Why?
|
| Microbiological Techniques | 1 | 2008 | 97 | 0.020 |
Why?
|
| Cefamandole | 1 | 1987 | 9 | 0.020 |
Why?
|
| Shigella dysenteriae | 1 | 1987 | 14 | 0.020 |
Why?
|
| Ciprofloxacin | 1 | 2009 | 312 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2010 | 749 | 0.020 |
Why?
|
| Sheep | 1 | 1990 | 1440 | 0.020 |
Why?
|
| Malnutrition | 1 | 2014 | 645 | 0.020 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2009 | 239 | 0.020 |
Why?
|
| Toxoids | 1 | 2007 | 11 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2015 | 10445 | 0.020 |
Why?
|
| Protein Conformation | 2 | 1992 | 3968 | 0.020 |
Why?
|
| Lepidoptera | 1 | 2007 | 24 | 0.020 |
Why?
|
| Enzyme Induction | 1 | 1987 | 452 | 0.020 |
Why?
|
| Autoantigens | 1 | 2011 | 891 | 0.020 |
Why?
|
| Water Microbiology | 1 | 2007 | 113 | 0.020 |
Why?
|
| Toll-Like Receptor 2 | 1 | 2009 | 347 | 0.020 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 149 | 0.020 |
Why?
|
| beta-Galactosidase | 1 | 1988 | 574 | 0.020 |
Why?
|
| Interleukin-13 | 1 | 2009 | 392 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 2007 | 659 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 2 | 1998 | 825 | 0.020 |
Why?
|
| Length of Stay | 1 | 2000 | 6425 | 0.020 |
Why?
|
| Cyclic GMP | 1 | 2007 | 395 | 0.020 |
Why?
|
| Penicillin Resistance | 2 | 1983 | 74 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2004 | 22169 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1988 | 779 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2009 | 553 | 0.020 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2012 | 1188 | 0.020 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 666 | 0.020 |
Why?
|
| Treatment Outcome | 6 | 2009 | 64680 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2004 | 11742 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2015 | 2856 | 0.020 |
Why?
|
| Prevalence | 2 | 2015 | 15732 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2015 | 3442 | 0.020 |
Why?
|
| Larva | 1 | 2007 | 508 | 0.020 |
Why?
|
| Heart Block | 1 | 1986 | 386 | 0.020 |
Why?
|
| Neutralization Tests | 1 | 2007 | 728 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 113 | 0.020 |
Why?
|
| Mezlocillin | 1 | 1984 | 3 | 0.010 |
Why?
|
| Moxalactam | 1 | 1984 | 9 | 0.010 |
Why?
|
| Cefoperazone | 1 | 1984 | 7 | 0.010 |
Why?
|
| NF-kappa B | 1 | 2013 | 2490 | 0.010 |
Why?
|
| Cefotaxime | 1 | 1984 | 35 | 0.010 |
Why?
|
| Transduction, Genetic | 1 | 1987 | 903 | 0.010 |
Why?
|
| Piperacillin | 1 | 1984 | 37 | 0.010 |
Why?
|
| Peroxidases | 1 | 2004 | 134 | 0.010 |
Why?
|
| Transplantation, Homologous | 2 | 2004 | 4806 | 0.010 |
Why?
|
| Cross Infection | 1 | 1993 | 1422 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2001 | 7390 | 0.010 |
Why?
|
| Aminoglycosides | 1 | 1984 | 160 | 0.010 |
Why?
|
| Tricuspid Valve | 1 | 1986 | 410 | 0.010 |
Why?
|
| Muramoylpentapeptide Carboxypeptidase | 1 | 1983 | 26 | 0.010 |
Why?
|
| Genes | 1 | 1987 | 1823 | 0.010 |
Why?
|
| Peptidyl Transferases | 1 | 1983 | 55 | 0.010 |
Why?
|
| Hexosyltransferases | 1 | 1983 | 58 | 0.010 |
Why?
|
| Clavulanic Acids | 1 | 1982 | 11 | 0.010 |
Why?
|
| Carbenicillin | 1 | 1982 | 12 | 0.010 |
Why?
|
| Clavulanic Acid | 1 | 1982 | 19 | 0.010 |
Why?
|
| Thienamycins | 1 | 1982 | 29 | 0.010 |
Why?
|
| Sulbactam | 1 | 1982 | 31 | 0.010 |
Why?
|
| Imipenem | 1 | 1982 | 37 | 0.010 |
Why?
|
| Massachusetts | 1 | 1995 | 8830 | 0.010 |
Why?
|
| Penicillanic Acid | 1 | 1982 | 42 | 0.010 |
Why?
|
| Tissue Donors | 2 | 2004 | 2331 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3087 | 0.010 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 2735 | 0.010 |
Why?
|
| Gastric Acid | 1 | 2002 | 99 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 1246 | 0.010 |
Why?
|
| Americas | 1 | 2001 | 111 | 0.010 |
Why?
|
| Kanamycin Kinase | 1 | 1981 | 34 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2017 | 3429 | 0.010 |
Why?
|
| Pregnancy | 3 | 2015 | 29874 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2008 | 2329 | 0.010 |
Why?
|
| Bacteriocins | 1 | 2001 | 88 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2005 | 1606 | 0.010 |
Why?
|
| Blood Group Incompatibility | 1 | 2002 | 135 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1984 | 1705 | 0.010 |
Why?
|
| Gram-Positive Bacteria | 1 | 2001 | 177 | 0.010 |
Why?
|
| Chloramphenicol | 1 | 1980 | 67 | 0.010 |
Why?
|
| Antifungal Agents | 1 | 2005 | 752 | 0.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2014 | 4580 | 0.010 |
Why?
|
| Phosphotransferases | 1 | 1981 | 303 | 0.010 |
Why?
|
| Graft Survival | 2 | 2001 | 3819 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 1986 | 2358 | 0.010 |
Why?
|
| Skin Diseases | 2 | 1997 | 1094 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 3429 | 0.010 |
Why?
|
| Lymphocyte Culture Test, Mixed | 1 | 2000 | 509 | 0.010 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 292 | 0.010 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 1999 | 92 | 0.010 |
Why?
|
| ras Proteins | 1 | 2004 | 1054 | 0.010 |
Why?
|
| Apoptosis | 1 | 2015 | 9486 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 2 | 2004 | 2688 | 0.010 |
Why?
|
| Bacillus subtilis | 1 | 2001 | 351 | 0.010 |
Why?
|
| Mitral Valve | 1 | 1986 | 1465 | 0.010 |
Why?
|
| Splenectomy | 1 | 1999 | 391 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 11076 | 0.010 |
Why?
|
| Drug Interactions | 1 | 1982 | 1416 | 0.010 |
Why?
|
| Cytarabine | 1 | 1999 | 697 | 0.010 |
Why?
|
| Brain | 1 | 2004 | 27112 | 0.010 |
Why?
|
| Peptides | 1 | 2009 | 4358 | 0.010 |
Why?
|
| Heart Failure | 1 | 2001 | 11669 | 0.010 |
Why?
|
| Platelet Transfusion | 1 | 2000 | 297 | 0.010 |
Why?
|
| Cyclosporine | 1 | 1999 | 778 | 0.010 |
Why?
|
| Colonic Neoplasms | 1 | 1989 | 2538 | 0.010 |
Why?
|
| Drug Synergism | 1 | 1981 | 1755 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 1980 | 335 | 0.010 |
Why?
|
| Aortic Valve | 1 | 1986 | 1955 | 0.010 |
Why?
|
| Chromosome Deletion | 2 | 1992 | 1386 | 0.010 |
Why?
|
| HLA Antigens | 1 | 2002 | 1328 | 0.010 |
Why?
|
| Cell Survival | 2 | 1999 | 5791 | 0.010 |
Why?
|
| Reoperation | 1 | 1986 | 4303 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2001 | 730 | 0.010 |
Why?
|
| Hematologic Diseases | 1 | 1980 | 496 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2003 | 1616 | 0.010 |
Why?
|
| Remission Induction | 1 | 2001 | 2396 | 0.010 |
Why?
|
| Pneumonia | 1 | 1987 | 2143 | 0.010 |
Why?
|
| Sex Factors | 2 | 1986 | 10552 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 1699 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2009 | 4486 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2009 | 7967 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2000 | 1756 | 0.010 |
Why?
|
| Developing Countries | 1 | 2006 | 2885 | 0.010 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2003 | 2865 | 0.010 |
Why?
|
| RNA | 1 | 2003 | 2726 | 0.010 |
Why?
|
| Aged, 80 and over | 4 | 2010 | 58976 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 1980 | 757 | 0.010 |
Why?
|
| Software | 1 | 1986 | 4434 | 0.010 |
Why?
|
| Fungemia | 1 | 1992 | 57 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1993 | 384 | 0.010 |
Why?
|
| Respiratory Tract Infections | 1 | 2000 | 1010 | 0.010 |
Why?
|
| Pregnancy Outcome | 1 | 2002 | 2921 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1999 | 6132 | 0.010 |
Why?
|
| Drug Hypersensitivity | 1 | 1980 | 917 | 0.010 |
Why?
|
| Anticoagulants | 1 | 1986 | 4812 | 0.010 |
Why?
|
| Aspergillosis | 1 | 1992 | 242 | 0.010 |
Why?
|
| X-Ray Diffraction | 1 | 1991 | 421 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2011 | 23995 | 0.010 |
Why?
|
| Lung Diseases | 1 | 1980 | 1909 | 0.010 |
Why?
|
| Aging | 1 | 2008 | 8708 | 0.010 |
Why?
|
| Nervous System Diseases | 1 | 1980 | 1666 | 0.010 |
Why?
|
| Drug Therapy, Combination | 2 | 1991 | 6310 | 0.010 |
Why?
|
| Kidney Diseases | 1 | 1980 | 2091 | 0.000 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1992 | 1693 | 0.000 |
Why?
|
| Liver Diseases | 1 | 1997 | 1298 | 0.000 |
Why?
|
| Pneumococcal Infections | 1 | 1993 | 501 | 0.000 |
Why?
|
| Pilot Projects | 1 | 2001 | 8631 | 0.000 |
Why?
|
| Protein Binding | 1 | 2000 | 9351 | 0.000 |
Why?
|
| Trypsin | 1 | 1988 | 495 | 0.000 |
Why?
|
| Proportional Hazards Models | 1 | 2001 | 12463 | 0.000 |
Why?
|
| Lactams | 1 | 1987 | 156 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2002 | 9318 | 0.000 |
Why?
|
| Glutamates | 1 | 1988 | 389 | 0.000 |
Why?
|
| Retinal Diseases | 1 | 1992 | 705 | 0.000 |
Why?
|
| Registries | 1 | 2001 | 8224 | 0.000 |
Why?
|
| Creatinine | 1 | 1991 | 1899 | 0.000 |
Why?
|
| Injections, Intravenous | 1 | 1987 | 1379 | 0.000 |
Why?
|
| Cephalothin | 1 | 1983 | 28 | 0.000 |
Why?
|
| Penicillin G | 1 | 1983 | 40 | 0.000 |
Why?
|
| Protoplasts | 1 | 1983 | 45 | 0.000 |
Why?
|
| Microscopy, Fluorescence | 1 | 1990 | 2645 | 0.000 |
Why?
|
| Actins | 1 | 1990 | 2050 | 0.000 |
Why?
|
| Urine | 1 | 1983 | 362 | 0.000 |
Why?
|
| Penicillin-Binding Proteins | 1 | 1983 | 148 | 0.000 |
Why?
|
| Boston | 1 | 1993 | 9326 | 0.000 |
Why?
|
| Seizures | 1 | 1993 | 2957 | 0.000 |
Why?
|
| Hospital Mortality | 1 | 1993 | 5294 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 1988 | 5112 | 0.000 |
Why?
|
| Kidney | 1 | 1991 | 7048 | 0.000 |
Why?
|
| Electrocardiography | 1 | 1987 | 6377 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1983 | 3688 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1987 | 8002 | 0.000 |
Why?
|